Logos Global Management »

Avalo Therapeutics Ord shares owned by Logos Global Management

Quarter-by-quarter ownership of Avalo Therapeutics Ord (AVTX) shares owned by Logos Global Management from 13F filings

Historical chart of Logos Global Management investment in Avalo Therapeutics Ord

Tip: Access up to 7 years of quarterly data

All positions including Avalo Therapeutics Ord held by Logos Global Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Avalo Therapeutics Ord by Logos Global Management

Quarter filed Position value Share count Share price at filing
2024-06-30 $6.7M 539k 12.47

More positions owned by Logos Global Management

Spdr Ser Tr S&p Biotech Put Option (XBI)
Spdr Ser Tr S&p Biotech Put Option (XBI)
Sarepta Therapeutics (SRPT)
Sarepta Therapeutics Call Option (SRPT)
Apellis Pharmaceuticals Call Option (APLS)
Apellis Pharmaceuticals (APLS)
Structure Therapeutics Sponsored Ads Call Option (GPCR)
Structure Therapeutics Sponsored Ads (GPCR)
Ideaya Biosciences (IDYA)
Ideaya Biosciences (IDYA)
Argenx Se Sponsored Adr (ARGX)
Argenx Se Sponsored Adr (ARGX)
Merus N V (MRUS)
Merus N V (MRUS)
Revolution Medicines (RVMD)

View all positions for Logos Global Management

Top funds holding Avalo Therapeutics Ord

Logos Global Management
Sio Capital Management
Ikarian Capital
Affinity Asset Advisors
Commodore Capital
Vanguard Group
Bank of America Corporation
Royal Bank of Canada
Banque Cantonale Vaudoise
BlackRock
Morgan Stanley
Efficient Wealth Management
Bnp Paribas Arbitrage, Snc
Group One Trading
Jpmorgan Chase & Co

View all funds holding Avalo Therapeutics Ord